Point of Care Tests in the Management of Very Early Medical Abortion

Recruiting now

Conditions studied: Abortion Early

In brief

This study will investigate the use of a point of care test in patients who are having an abortion at a gestation of \<6 weeks (known as a very early medical abortion). These patients have pregnancy hormone level checked at Day 0 and Day 7 to see if treatment has worked. The investigators plan to use a point of care test machine to see if it is possible to check pregnancy hormone level earlier than Day 7.

Key facts

Study ID

NCT07417787

Run by

University of Edinburgh

People needed

130

Starts

2026-04-23

Expected to finish

2028-02-01

Last updated by the study team

2026-06-03

Who can join

Age: 16 and older, up to 55. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Positive pregnancy test
• Less than six weeks gestation based upon Last Menstrual Period (LMP)
• No evidence of definite intrauterine pregnancy on ultrasound
• No signs or symptoms or significant risk factors for ectopic
• Wish to proceed to VEMA (Very Early Medical Abortion)
• Available for usual clinical follow up
• Willing to attend for serum Human Chorionic Gonadotropin (HCG) on two occasions Day 2-4 and Day 7 post mifepristone
• Written informed consent

You may not qualify if…

• Pain and/or bleeding
• Significant risk factors for ectopic (previous ectopic, sterilisation, tubal disease, intrauterine device in situ)
• Suspicious features for ectopic on ultrasound (adnexal mass, moderate free fluid)
• Unable to provide blood sample
• Lack of Capacity to consent

Where it is running

• Chalmers Sexual Health Clinic — Edinburgh, United Kingdom (enrolling)
• University of Gothenberg — Gothenburg, Sweden
• Karolinska Institutet — Stockholm, Sweden

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.